Aragen Life Sciences
- Company typePrivate
- Founded2001
- HeadquartersHyderabad, India
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
Aragen Life Sciences firmographics
Firmographics- Name
- Aragen Life Sciences
- Legal name
- Aragen Life Sciences Ltd.
- Website
- https://aragen.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Aragen Life Sciences industry classification
Industry- Product category
- Pharmaceutical Contract Research, Development and Manufacturing Services (CRDMO)
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE)
- akta.pro secondary industries
- GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)
Keywords
Where Aragen Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices13 records
Markets served
Aragen Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Contract Research Services: Integrated drug discovery services including chemistry, biology, bioinformatics, and ADME/PK studies for small and large molecules
- Contract Development and Manufacturing: GMP manufacturing of drug substances and drug products for clinical and commercial supply
- Technology Transfer Services: Tech transfer from early-phase development to clinical supply including cell line development and process optimization
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Aragen Life Sciences product offering
Product offeringCore offering
Aragen Life Sciences is a global Contract Research, Development and Manufacturing Organization (CRDMO) providing integrated drug discovery, development, and GMP manufacturing services for small and large molecules. Services span integrated drug discovery (chemistry, biology, biosafety, ADME/PK), drug substance and drug product development, analytical services, custom synthesis, and commercial manufacturing for small molecules, alongside antibody discovery, protein sciences, cell line development, bioprocessing, and GMP biologics manufacturing for large molecules. The company operates a dual-hub model with R&D in Morgan Hill, California, and GMP scale manufacturing in India, serving large pharma, biotech, agrochemical, and animal health clients.
Product overview
Aragen Life Sciences is a global CRDMO (Contract Research, Development, and Manufacturing Organization) offering integrated solutions across small and large molecules. The company operates a dual-hub model with R&D innovation in California (USA) and GMP scale manufacturing in India. Core services span Integrated Drug Discovery, Chemistry, Biology, BioSafety, Drug Substance, Drug Product, Analytical Development, Custom Chemical Synthesis, and Commercial Manufacturing for small molecules. For biologics, services include Integrated Discovery, Molecular Biology, Antibody Discovery, Protein Sciences, Cell Line Development, Process Research & Development, Bioproduction, and GMP Manufacturing. Notable platforms include CHOMax™ for accelerated DNA-to-IND timelines (~10 months) and the RapTr royalty-free cell line development platform. The company serves 400+ clients including 7 of 10 large pharma companies and 100+ biotechs globally.
Differentiator
Problem solved
Functional benefit
Brands
- CHOMax: Accelerated platform for DNA to IND-enabling clinical supply in approximately 10 months
- RapTr
Products and services
- Small Molecules Discovery Services Integrated drug discovery services for small molecule pharmaceutical programs, including integrated drug discovery, chemistry, biology, and biosafety assessment, advancing programs from early discovery through preclinical development for global pharma and biotech clients.
- Small Molecules Development and Manufacturing Services End-to-end small molecule services including drug substance, drug product, analytical development, custom chemical synthesis, performance chemicals, and commercial manufacturing for global pharmaceutical clients.
- Large Molecules (Biologics) Discovery Services Comprehensive biologics discovery services including integrated discovery, biology, molecular biology, antibody discovery, protein sciences, and cell line development for large molecule therapeutics.
- Large Molecules (Biologics) Development and Manufacturing Services Process research and development, bioproduction, developability and analytics, and GMP manufacturing services for biologics including monoclonal antibodies, with R&D delivered from California and manufacturing executed in India.
- CHOMax™ Platform Proprietary accelerated biologics platform that compresses DNA to IND-Enabling Clinical Supply timelines to approximately 10 months for biotech and pharma clients.
- RapTr Cell Line Development Platform Royalty-free CHO GS cell line development platform enabling biologics developers to access cell line development without royalty obligations, offered as part of Aragen's biologics services.
- ChemiSHE Women's Chemistry Synthesis Laboratory India's first women-led chemistry synthesis laboratory providing specialized medicinal and synthetic chemistry services with a focus on gender diversity in scientific research.
Quantifiable outcome
- ₹12,200 crore ($1.4 billion) valuation
- +2 more outcomes
Companies that use Aragen Life Sciences
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles3 records
Aragen Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
Aragen Life Sciences partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, major and minor.
- Renaissance Pharma (Essential Pharma)coreStrategic collaboration for manufacturing Renaissance Pharma's FDA Fast Track designated mAb Daretabart. Aragen developed cell line and process at Morgan Hill site, with GMP manufacturing transitioned to Bengaluru facility. Successfully manufactured first commercial-scale GMP batches in 9 months.
- Boehringer IngelheimcoreExpanded discovery research agreement with Boehringer Ingelheim covering multiple programs in drug discovery services.
- MSDcoreDiscovery services partnership to support MSD's global R&D operations.
- Blueprint MedicinescoreExpanded collaboration in biologics development for Blueprint Medicines' pipeline.
- FMC CorporationmajorMulti-year partnership to accelerate agro-chemical pipeline development.
- Skyhawk TherapeuticsmajorCollaboration to develop novel small molecule therapeutics correcting RNA expression.
- NeoVacmajorExtended collaboration to manufacture lipid products for next-generation lipid nanoparticles (LNP) for RNA vaccines.
- Warrantee Inc.minorJoint development of hair growth active ingredient 'Isopropyl Dimethyl Norcarboprost' with patent registration in Japan and international filings.
- DevsHealthminorStrategic partnership for chemical synthesis of DevsHealth projects.
- DHL Express IndiaminorGoGreen Plus partnership to reduce carbon emissions in logistics operations.
- CSIR-IICT and KewauneeminorMOU for offering 'Finishing School' skill program to postgraduate students in Chemistry.
Scale indicators10 records
Recent moves13 records
Expansion highlights6 records
Aragen Life Sciences competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Swiss global CDMO leader with extensive biologics and small molecule manufacturing capacity. Sets the bar for commercial-scale biologics capability and competes for top-20 pharma MSAs.
- WuXi AppTec: China-headquartered global CRDMO with broad services across small molecules, biologics, and cell/gene therapy. The dominant scale competitor whose geopolitical risk is the source of Aragen's 'China+1' opportunity.
- Curia (formerly Albany Molecular Research): US-headquartered CDMO with discovery, development, and commercial manufacturing capabilities across small molecules and biologics. Competes for integrated programs with biotech and mid-pharma.
- Catalent: US-headquartered CDMO with strong biologics and oral dose capabilities, now owned by Novo Holdings. Direct competitor for biologics manufacturing and integrated development programs.
- Thermo Fisher Scientific (Pharma Services): Diversified life sciences giant with a substantial CDMO business including biologics, fill-finish, and clinical supply. Competes for large pharma outsourcing contracts across the value chain.
Direct peers
- Syngene International: India-based listed CRDMO offering integrated discovery, development, and manufacturing services to global pharma and biotech. Direct competitor with similar dual-hub ambitions and overlapping customer roster across small and large molecules.
- Piramal Pharma Solutions: India-headquartered CDMO providing drug substance, drug product, and biologics services globally. Comparable in integrated services model and customer base across large pharma.
- Sai Life Sciences: India-based CRO/CDMO offering discovery, development, and manufacturing services for small molecules. Direct competitor for discovery and chemistry services, with similar India-cost arbitrage model.
Emerging players
- Anthem Biosciences: India-based CRO/CDMO offering integrated drug discovery and development services. Emerging competitor for discovery chemistry and early development work with similar customer profiles.
Regional players
- Suven Pharmaceuticals: India-headquartered CRO/CDMO focused on contract research, development, and manufacturing for global pharma. Comparable in India cost-arbitrage positioning and discovery services portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Aragen Life Sciences social profiles
Digital presenceAragen Life Sciences compliance and trust
Trust signalCompliance10 records
Aragen Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aragen Life Sciences leadership team
Management profileNumber of profiles
Profiles11 records
Aragen Life Sciences subsidiaries and ownership
Company hierarchySubsidiaries1 record
Aragen Life Sciences funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aragen Life Sciences M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aragen Life Sciences
What does Aragen Life Sciences do?
Aragen Life Sciences is a global Contract Research, Development and Manufacturing Organization (CRDMO) providing integrated drug discovery, development, and GMP manufacturing services for small and large molecules. Services span integrated drug discovery (chemistry, biology, biosafety, ADME/PK), drug substance and drug product development, analytical services, custom synthesis, and commercial manufacturing for small molecules, alongside antibody discovery, protein sciences, cell line development, bioprocessing, and GMP biologics manufacturing for large molecules. The company operates a dual-hub model with R&D in Morgan Hill, California, and GMP scale manufacturing in India, serving large pharma, biotech, agrochemical, and animal health clients.
Is Aragen Life Sciences a public or private company?
Aragen Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aragen Life Sciences founded?
Aragen Life Sciences was founded in 2001. It employs 1,001 to 5,000 people.
Where is Aragen Life Sciences based?
Aragen Life Sciences is headquartered in Hyderabad, India, in the Asia region.
How does Aragen Life Sciences make money?
Three revenue lines are on record. Contract Research Services are the primary driver. The others are contract Development and Manufacturing and technology Transfer Services.
Who are Aragen Life Sciences's main competitors?
Broad incumbents on record are Lonza Group, WuXi AppTec, Curia (formerly Albany Molecular Research), Catalent and Thermo Fisher Scientific (Pharma Services). Direct peers are Syngene International, Piramal Pharma Solutions and Sai Life Sciences. Anthem Biosciences is listed as an emerging player. Suven Pharmaceuticals is listed as a regional player.
Does Aragen Life Sciences have an API?
No public API is recorded for Aragen Life Sciences.
What industry is Aragen Life Sciences in?
Aragen Life Sciences's product category is Pharmaceutical Contract Research, Development and Manufacturing Services (CRDMO). Its primary akta.pro industry code is HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT), with a secondary code of HLAGAGAL, GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification). Its NAICS code is 5417 and its SIC code is 8731.